Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 71,040 | 58,393 | 60,402 | 57,916 | 65,187 |
| Cost of Goods | 44,976 | 41,421 | 40,021 | 37,363 | 38,440 |
| Gross Profit | 26,064 | 16,972 | 20,381 | 20,553 | 26,747 |
| Operating Expenses | 29,981 | 27,170 | 22,317 | 23,859 | 25,002 |
| Operating Income | -2,941 | -9,777 | -1,915 | -2,943 | 2,185 |
| Interest Expense | 100 | 18 | 134 | 264 | 237 |
| Other Income | -1,159 | 906 | 735 | 1,093 | 1,225 |
| Pre-tax Income | -4,200 | -8,889 | -1,314 | -2,114 | 3,173 |
| Income Tax | -1,347 | -1,748 | -1,997 | -2,213 | 1,201 |
| Net Income Continuous | -2,853 | -7,141 | 683 | 99 | 1,972 |
| Net Income | $-2,853 | $-7,141 | $683 | $99 | $1,972 |
| EPS Basic Total Ops | -0.06 | -0.15 | 0.02 | 0.00 | 0.04 |
| EPS Basic Continuous Ops | -0.06 | -0.15 | 0.01 | 0.00 | 0.04 |
| EPS Diluted Total Ops | -0.06 | -0.15 | 0.02 | 0.00 | 0.04 |
| EPS Diluted Continuous Ops | -0.06 | -0.15 | 0.01 | 0.00 | 0.04 |
| EBITDA(a) | $1,234 | $-5,988 | $2,088 | $1,203 | $6,025 |